Takeda hire indicates broad change

Share this article:

Takeda's new president is getting attention. The company announced last week that it named former GSK-er Chris Weber CEO. The New York Times noted in its coverage that appointing a French citizen is in line with a trend among Japanese companies to look abroad for hires, and Bloomberg noted Wednesday that Weber not only lacks Takeda experience, but is also the first non-Japanese executive to lead the company.

Weber is expected to be named CEO in April, when Yasuchika Hasegawa leaves. Robert Dujarric of the Institute of Contemporary Asian Studies at Temple University told Bloomberg that the unique hire has a benefit beyond just being different. “A guy who's not from Takeda, whether he's Japanese or foreign, can much more easily fire people, restructure and close businesses,” he said.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.